Cystic fibrosis related diabetes

Practical Diabetes International

Volumn 27, Issue 5, 2010, Pages 198-200

  Alexander, Saji ^a   Bridges, Nicola ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Continuous glucose monitoring systems; Cystic fibrosis; Cystic fibrosis related diabetes; Lung function

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; BLOOD GLUCOSE MONITORING; COMORBIDITY; CYSTIC FIBROSIS; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; LUNG DISEASE; LUNG FUNCTION; MICROALBUMINURIA; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; NUTRITIONAL DISORDER; ORAL GLUCOSE TOLERANCE TEST; PHYSIOTHERAPY; PREVALENCE; RISK REDUCTION; SCREENING; STOMACH DISEASE; SURVIVAL; VASCULAR DISEASE;

EID: 77953951602     PISSN: 13578170     EISSN: 1528252X     Source Type: Journal    
DOI: 10.1002/pdi.1481     Document Type: Article

References (15)

1. Moran A, Dunitz J, Nathan B, et al. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009; 32: 1626-1631.
2. Löhr MP, Goertchen H, Nizze N, et al. Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study. Virchows Arch A Pathol Anat Histopathol 1989; 414: 179-185.
3. Yung B, Noormohamed FH, Kemp M, et al. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta cell dysfunction. Diabet Med 2002; 19: 221-226. (Pubitemid 34429653)
4. Lanng S. Glucose intolerance in cystic fibrosis patients. Paediatr Respir Rev 2001; 2: 253-259. (Pubitemid 34460746)
5. Adler AI, Shine BSF, Chamnan P, et al. Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults. Diabetes Care 2008; 31: 1789-1794.
6. Rolon MA, Benali K, Munck A, et al. Cystic fibrosis related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001; 90: 860-867.
7. Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005; 28: 2141-2144. (Pubitemid 41242458)
8. Cheung MS, Bridges NA, Prasad SA, et al. Growth in children with cystic fibrosis-related diabetes. Pediatr Pulmonol 2009; 44: 1223-1225.
9. Bismuth E, Laborde K, Taupin P, et al. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J Pediatr 2008; 152: 540-545.e1.
10. Moran A, Pekow P, Grover P, et al. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial. Diabetes Care 2009; 32: 1783-1788.
11. Bizzarri C, Lucidi V, Ciampalini P, et al. Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance. J Endocrinol Invest 2006; 29: RC1-4.
12. van den Berg JM, Morton AM, Kok SW, et al. Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD). J Cyst Fibros 2008; 7: 515-519.
13. UK Cystic Fibrosis Trust Working Group. Management of cystic fibrosis related diabetes mellitus 2004. www.cftrust.org.uk/aboutcf/publications/ consensusdoc/diabetes.pdf.
14. Dobson L, Sheldon CD, Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 2004; 21: 691-696. (Pubitemid 38916212)
15. Hameed S, Morton JR, Jaffé A, et al. Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain. Diabetes Care 2010; 33: 221-226.